Abstract
As a therapy for type I diabetes, islet transplantation provides clear benefits in terms of increased insulinindependence and a reduced risk of hypoglycemia. However, a critical shortage of donor pancreata means that few can benefit from this approach. The ex vivo expansion of human β-cells prior to transplantation could ameliorate this problem, however, attempts to grow large numbers of β-cells that retain their native phenotype have thus far failed. Recent lineage tracing studies suggest that this problem is due to the inherent tendency of cultured human β-cells to undergo a process reminiscent of epithelial-to-mesenchymal transition (EMT). EMT describes a highly complex process that culminates in a loss of epithelial cell polarity, severance of intercellular adhesive junctions and the acquisition of a highly motile mesenchymal phenotype. Interestingly, recent evidence suggests that a transient EMT-like process may also contribute to the delamination of endocrine progenitors and subsequent islet neogenesis. The inherent susceptibility of cultured human β-cells to EMT, and the potential involvement of this process during islet neogenesis, raises important questions as to how this process is triggered and subsequently regulated. The primary purpose of this review is to describe those factors, pathways or processes that are complicit in inducing or regulating the mesenchymal transition of human β-cells. This includes addressing the role of the extracellular matrix, the contribution of select signaling pathways, and the regulatory function of microRNAs. We propose that manipulation of these cues and pathways offers the greatest potential for restoring β-cell function after ex vivo expansion.
Keywords: β-Cells, Cell-based therapy, Epithelial-to-mesenchymal transition, Extracellular matrix, Islet neogenesis, Signaling, Hepatocyte growth factor, Cyto-nuclear translocation, beta-Cell Transition, N-cadherin, E-cadherin
Current Diabetes Reviews
Title: The Epithelial-to-Mesenchymal Transition of Human Pancreatic β-Cells: Inductive Mechanisms and Implications for the Cell-Based Therapy of Type I Diabetes
Volume: 7 Issue: 5
Author(s): Anthony M.P. Montgomery and Mayra Yebra
Affiliation:
Keywords: β-Cells, Cell-based therapy, Epithelial-to-mesenchymal transition, Extracellular matrix, Islet neogenesis, Signaling, Hepatocyte growth factor, Cyto-nuclear translocation, beta-Cell Transition, N-cadherin, E-cadherin
Abstract: As a therapy for type I diabetes, islet transplantation provides clear benefits in terms of increased insulinindependence and a reduced risk of hypoglycemia. However, a critical shortage of donor pancreata means that few can benefit from this approach. The ex vivo expansion of human β-cells prior to transplantation could ameliorate this problem, however, attempts to grow large numbers of β-cells that retain their native phenotype have thus far failed. Recent lineage tracing studies suggest that this problem is due to the inherent tendency of cultured human β-cells to undergo a process reminiscent of epithelial-to-mesenchymal transition (EMT). EMT describes a highly complex process that culminates in a loss of epithelial cell polarity, severance of intercellular adhesive junctions and the acquisition of a highly motile mesenchymal phenotype. Interestingly, recent evidence suggests that a transient EMT-like process may also contribute to the delamination of endocrine progenitors and subsequent islet neogenesis. The inherent susceptibility of cultured human β-cells to EMT, and the potential involvement of this process during islet neogenesis, raises important questions as to how this process is triggered and subsequently regulated. The primary purpose of this review is to describe those factors, pathways or processes that are complicit in inducing or regulating the mesenchymal transition of human β-cells. This includes addressing the role of the extracellular matrix, the contribution of select signaling pathways, and the regulatory function of microRNAs. We propose that manipulation of these cues and pathways offers the greatest potential for restoring β-cell function after ex vivo expansion.
Export Options
About this article
Cite this article as:
M.P. Montgomery Anthony and Yebra Mayra, The Epithelial-to-Mesenchymal Transition of Human Pancreatic β-Cells: Inductive Mechanisms and Implications for the Cell-Based Therapy of Type I Diabetes, Current Diabetes Reviews 2011; 7 (5) . https://dx.doi.org/10.2174/157339911797415639
DOI https://dx.doi.org/10.2174/157339911797415639 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
Call for Papers in Thematic Issues
Advancing Diabetic Wound Healing: Mechanisms and Interventions
In recent years, diabetic wounds have become a global health concern with the increase in the incidence of diabetes. Diabetic wounds are a kind of chronic and refractory ulcer. It is generally due to the microcirculatory disturbances and the reduced levels of endogenous growth factors. Delayed cutaneous wound healing is ...read more
Oxidative and inflammatory responses in the development of secondary diabetic complications
Diabetes, along with its associated secondary complications, represents a significant global health challenge, contributing significantly to morbidity and mortality. Unhealthy lifestyle habits, reduced physical activity, environmental pollutants, and stress are pivotal factors in the onset of diabetes, particularly type-2 diabetes. Poorly managed hyperglycemia can lead to various complications, including neuropathy, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cytotoxic and Apoptotic Effect of <i>Iris taochia</i> Plant Extracts on Human
Breast Cancer (MCF-7) Cells
Current Proteomics Cancer Multitarget Pharmacology in Prostate Tumors: Tyrosine Kinase Inhibitors and Beyond
Current Medicinal Chemistry Age and High-Fat Diet Effects on Glutamine Synthetase Immunoreactivity in Liver and Hippocampus and Recognition Memory in Mice
Current Aging Science Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery
Recent Patents on Nanotechnology Involvement of the Transforming Growth Factor β in the Pathogenesis of Hereditary Hemorrhagic Telangiectasia
Current Pharmaceutical Design Anabolic Effects of Intermittent PTH on Osteoblasts
Current Molecular Pharmacology Freeze-Drying of Protein-Loaded Nanoparticles for Vaccine Delivery
Drug Delivery Letters Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents
Mini-Reviews in Medicinal Chemistry Pleiotropic Effects of Nifedipine on Atherosclerosis
Current Pharmaceutical Design Experimental Brain Ischemic Preconditioning: A Concept to Putative Targets
CNS & Neurological Disorders - Drug Targets A Role for Glucocorticoids in Thymic Involution?
Current Immunology Reviews (Discontinued) Visceral and Subcutaneous Adiposity: Are Both Potential Therapeutic Targets for Tackling the Metabolic Syndrome?
Current Pharmaceutical Design Estrogenic Compounds, Estrogen Receptors and Vascular Cell Signaling in the Aging Blood Vessels
Current Medicinal Chemistry Radix Astragali (Astragalus): Latest Advancements and Trends in Chemistry, Analysis, Pharmacology and Pharmacokinetics
Current Organic Chemistry Impact of Obstructive Sleep Apnea and Current Treatments on the Development and Progression of Type 2 Diabetes
Current Diabetes Reviews Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
Current Pharmaceutical Design The Impact of Cardiovascular Diseases on Cardiovascular Regulation During Exercise in Humans: Studies on Metaboreflex Activation Elicited by the Post-exercise Muscle Ischemia Method
Current Cardiology Reviews Design of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: A History Driven by Biology to Chemistry
Medicinal Chemistry Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis
Current Pharmaceutical Design Management of Prehypertension: Current Status and Future Strategies
Current Hypertension Reviews